IL116746A0 - Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions - Google Patents

Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions

Info

Publication number
IL116746A0
IL116746A0 IL11674696A IL11674696A IL116746A0 IL 116746 A0 IL116746 A0 IL 116746A0 IL 11674696 A IL11674696 A IL 11674696A IL 11674696 A IL11674696 A IL 11674696A IL 116746 A0 IL116746 A0 IL 116746A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
diphenyl chromans
chromans
diphenyl
Prior art date
Application number
IL11674696A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL116746A0 publication Critical patent/IL116746A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11674696A 1995-01-13 1996-01-12 Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions IL116746A0 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
DK4595 1995-01-13
DK4495 1995-01-13
DK4695 1995-01-13
DK4895 1995-01-13
DK4795 1995-01-13
DK77195 1995-06-30
DK77095 1995-06-30
DK76895 1995-06-30
DK77295 1995-06-30
DK76995 1995-06-30

Publications (1)

Publication Number Publication Date
IL116746A0 true IL116746A0 (en) 1996-05-14

Family

ID=27579214

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11674696A IL116746A0 (en) 1995-01-13 1996-01-12 Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions

Country Status (11)

Country Link
EP (1) EP0804190A1 (hu)
JP (1) JPH10511962A (hu)
CN (1) CN1168096A (hu)
AU (1) AU693628B2 (hu)
CA (1) CA2208861A1 (hu)
CZ (1) CZ212297A3 (hu)
HU (1) HUP9702244A3 (hu)
IL (1) IL116746A0 (hu)
MX (1) MX9705219A (hu)
NO (1) NO973243L (hu)
WO (1) WO1996021444A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
EP0934297A1 (en) * 1996-10-28 1999-08-11 Novo Nordisk A/S NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
CA2270111A1 (en) * 1996-10-28 1998-05-07 Lise Brown Christiansen Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
CA2270113A1 (en) * 1996-10-28 1998-05-07 Poul Jacobsen Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
DE69717843T2 (de) * 1996-10-28 2003-09-25 Novo Nordisk As Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
EP0934299A1 (en) * 1996-10-28 1999-08-11 Novo Nordisk A/S NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
US5994390A (en) * 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6316494B1 (en) 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5958967A (en) * 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129623A0 (en) * 1996-10-28 2000-02-29 Novo Nordisk As Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979644B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
DK0937062T3 (da) * 1996-10-28 2003-04-07 Novo Nordisk As Nye cis-3,4-chroman-derivater, der er nyttige i forebyggelsen eller behandlingen af østrogen-relaterede sygdomme eller syndromer
AU4772197A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
EP1282615B1 (en) 2000-03-01 2011-10-19 N.V. Organon Chroman derivatives as estrogenic compounds
EP2407462B1 (en) 2004-09-21 2014-07-30 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CA2816319C (en) 2010-11-01 2020-06-30 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
PT2953938T (pt) 2014-02-07 2017-10-09 Novogen ltd Compostos de benzopirano funcionais e sua utilização
PT3253208T (pt) 2015-02-02 2021-06-17 The Spanish National Cancer Res Centre Terapêuticas de combinação para utilização no tratamento do cancro da mama

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
MX9705219A (es) 1997-10-31
CN1168096A (zh) 1997-12-17
NO973243D0 (no) 1997-07-11
AU693628B2 (en) 1998-07-02
HUP9702244A3 (en) 1999-12-28
CZ212297A3 (en) 1997-11-12
EP0804190A1 (en) 1997-11-05
JPH10511962A (ja) 1998-11-17
CA2208861A1 (en) 1996-07-18
HUP9877967A2 (en) 1998-12-28
AU4329396A (en) 1996-07-31
WO1996021444A1 (en) 1996-07-18
NO973243L (no) 1997-07-11

Similar Documents

Publication Publication Date Title
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
NZ304982A (en) Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
HUP9904046A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing the same
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
IL118426A0 (en) Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
ZA967827B (en) Pharmaceutical compositions
PL322526A1 (en) Azathiopyrin compositions for intracolic administration
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
EG24294A (en) Pharmaceutical compositions
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
IL116826A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
IL117806A0 (en) 1,3-Dihydro-2h-imidazol-2-one derivatives their preparation and pharmaceutical compositions containing them
IL116827A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116747A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9900079A3 (en) 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
IL118365A0 (en) Quinoxalinedione derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
HUP9600061A2 (en) 3-alkoxycarbonyl-1,3,4-thiadiazin-2-on derivatives, process for their preparation and pharmaceutical compositions containing the same